Two CLL Couples Connect: Our Shared Experiences Patient Power Founder Andrew Schorr was treated at MD Anderson Cancer Center more than 17 years ago with FCR (fludarabine, cyclophosphamide, rituximab) to combat his CLL. In 2017, Andrew’s physician decided it was time to treat again, so he has begun infusion with obinutuzumab (Gazyva). Fellow CLL patient Mickey’s treatment path is almost identical to Andrew’s. Joined by their wives—Esther and Robin—they meet virtually to share their experiences and insights. Get email alerts | Subscribe on YouTube | Like on Facebook | Follow on Twitter | Follow on Google+ |